Status:
COMPLETED
A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborating Sponsors:
Otsuka America Pharmaceutical
Conditions:
Bipolar I Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate several doses of aripiprazole in patients with bipolar depression.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Men and women, ages 18-65
- Have experienced a prior manic episode that required treatment with a mood stabilizer or antipsychotic, and now meet criteria for a major depressive episode.
Exclusion
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
End Date :
November 1 2006
Estimated Enrollment :
650 Patients enrolled
Trial Details
Trial ID
NCT00094432
Start Date
June 1 2004
End Date
November 1 2006
Last Update
November 11 2013
Active Locations (40)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Mesa, Arizona, United States
2
Local Institution
La Mesa, California, United States
3
Local Institution
La Palma, California, United States
4
Local Institution
Long Beach, California, United States